Transcriptome analysis of Burkitt lymphoma cells treated with anti-convulsant drugs that are inhibitors of Epstein-Barr virus lytic reactivation.
Herpesviruses have two distinct life cycle stages, latency and lytic replication. Epstein-Barr virus (EBV), a gamma-herpesvirus, establishes latency in vivo and in cultured cells. Cell lines harboring latent EBV can be induced into the lytic cycle by treatment with chemical inducing agents. In the B...
Auteurs principaux: | Kelly L Gorres, David M Reineke, George Miller |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Public Library of Science (PLoS)
2024-01-01
|
Collection: | PLoS ONE |
Accès en ligne: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0299198&type=printable |
Documents similaires
-
Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus
par: Kelly L. Gorres, et autres
Publié: (2016-05-01) -
Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine
par: Abbie G. Anderson, et autres
Publié: (2019-05-01) -
Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus
par: Rebecca L. Hutcheson, et autres
Publié: (2021-01-01) -
Identification of Epstein-Barr Virus Replication Proteins in Burkitt’s Lymphoma Cells
par: Chris Traylen, et autres
Publié: (2015-10-01) -
Zebularine reactivates silenced <it>E-cadherin </it>but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells
par: Nadal David, et autres
Publié: (2007-01-01)